The global enzyme replacement therapy market was valued at USD 13.45 billion in 2023 and is projected to grow from USD 14.61 billion in 2024 to USD 29.49 billion by 2032, at a compound annual growth rate (CAGR) of 9.2% during the forecast period. North America led the market in 2023, holding a 47.96% share.
